Electronic Health Records
Conditions
Brief summary
The objective is to evaluate the impact of an electronic pharmaceutical record used for medication reconciliation by a pharmacist associated to the anesthesiologist consultation Experimental intervention: medication reconciliation by a pharmacist using an electronic pharmaceutical record before the anesthesiologist consultation for planned surgery patients. The clinical pharmacist communicates the recommendations regarding the drug therapy to the anesthesiologist orally and using a specific formulary. Control intervention: Conventional anesthesiologist consultation for planned surgery patients.
Detailed description
Anesthesiology consultation is mandatory in France for planned surgery. It is part of the concept of anesthesia safety. The main goal is to assess the anesthetic and surgical risk including clinical and drug features likely to interfere with the anesthesia. The medication reconciliation is a central part of this consultation especially in order to assess the allergic risk and hemostasis disorders. However, access to comprehensive and reliable data concerning the consumption of health products by the patient represents a major challenge. The Dossier Pharmaceutique (DP) is an electronic pharmaceutical record including medications (prescribed medications, over the counter medications, complementary and alternative medicines) delivered by community pharmacists over a four month period. Hospital pharmacists have access to the DP of hospitalized patients in order to improve the quality of the medication reconciliation. These informations regarding medication of the patients will be shared with anesthesiologists.
Interventions
OTHERDP medication reconciliation
Sponsors
University Hospital, Grenoble
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* patient coming for anesthetics consultation before a planned surgery * age above18 * available electronic pharmaceutical record (DP) * at least one medication prescribed before hospital admission
Exclusion criteria
* Minor patients ou majors protected by law * Not speaking French patient * Person who are not free by law or administrative decision
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of participants with a potential or documented adverse drug event collected by using trigger tool method | within the first 30 days after surgery |
Secondary
| Measure | Time frame |
|---|---|
| Number of medications reported by the anesthesiologist in the medical record | winthin 2 to 4 weeks between anesthesiogist consultation and surgery |
Other
| Measure | Time frame |
|---|---|
| Demographic, clinical and therapeutic characteristics of all included participants | at inclusion |
| Number of participants having an electronic pharmaceutical record (DP) open | at inclusion |
| Number of participants with a documented adverse drug event over the perioperative period | within the first 30 days after surgery |
Countries
France
Outcome results
None listed